1,129
Participants
Start Date
June 19, 2019
Primary Completion Date
January 6, 2020
Study Completion Date
June 22, 2020
FD MVA-BN
Vaccinations with a 0.5 mL dose of vaccine containing at least 0.5 x 10E8 Infectious Units (Inf.U)
Rochester Clinical Research, Inc., Rochester
Optimal Research, LLC (Synexus), Rockville
M3 Wake Research, Inc., Raleigh
Optimal Research, LLC (Synexus), Melbourne
University of Alabama at Birmingham, Birmingham
University of Kentucky Healthcare Chandler Hospital, Lexington
University of Iowa, Iowa City
Optimal Research, LLC (Synexus), Peoria
Saint Louis University, St Louis
Washington University School of Medicine, St Louis
Lynn Health Science Institute, Oklahoma City
Omega Medical Research, Warwick
Lead Sponsor
Biomedical Advanced Research and Development Authority
FED
Bavarian Nordic
INDUSTRY